Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Integrative analyses to identify genetic determinants of immune responsiveness in cancer

Share :

Milan Summit On Precision Medicine
Published: 21 Feb 2018
Views: 5197
Rating:
Save
Dr Davide Bedognetti - Sidra Medical and Research Center, Doha, Qatar

Dr Davide Bedognetti presents at ecancer's Milan Summit on Precision Medicine 2018 about immune responsiveness in cancer.

He discusses the genetic determinants behind this, touching upon the Immunologic Constant of Rejection (ICR) pathways and genes involved.

The webcast has been supported by an unrestricted educational grant from Roche Foundation Medicine

Related Videos

ESMO 2024: Optimising the personalisation of prostate cancer treatment
Prof Alison Birtle, Dr Alejo Rodríguez-Vida, Dr Pasquale Rescigno and Prof...
ESMO 2024: Optimising the personalisation of prostate cancer treatment ( Prof Alison Birtle, Dr Alejo Rodríguez-Vida, Dr Pasquale Rescigno and Prof Gunhild von Amsberg )
15 Sep 2024
Multiple myeloma In Rwanda: The need for further research
Dr Eulade Rugengamanzi - Butaro Hospital, Ministry of Health, Rwanda
Multiple myeloma In Rwanda: The need for further research ( Dr Eulade Rugengamanzi - Butaro Hospital, Ministry of Health, Rwanda )
6 Aug 2024
GIST tumours and soft tissue sarcomas
Dr Atif Hussein - Memorial Cancer Institute, Miami, USA
GIST tumours and soft tissue sarcomas ( Dr Atif Hussein - Memorial Cancer Institute, Miami, USA )
12 Jul 2024
Multiple myeloma in a resource constrained setting
Dr Henry Ddungu - Uganda Cancer Institute, Kampala, Uganda
Multiple myeloma in a resource constrained setting ( Dr Henry Ddungu - Uganda Cancer Institute, Kampala, Uganda )
22 Feb 2024
Remote genetic testing has the potential to increase the uptake of testing in...
Dr Bruce Montgomery - University of Washington, Seattle, USA
Remote genetic testing has the potential to increase the uptake of testing in large integrated healthcare systems ( Dr Bruce Montgomery - University of Washington, Seattle, USA )
31 Jan 2024
Relapsed Refractory Multiple Myeloma
Dr Hari Menon - St. Johns National Academy of Health Sciences, Bengaluru, India
Relapsed Refractory Multiple Myeloma ( Dr Hari Menon - St. Johns National Academy of Health Sciences, Bengaluru, India )
5 Dec 2023
Erdafitinib and current treatment landscape for advanced bladder cancer
Dr Yohann Loriot and Prof Arlene Siefker-Radtke
Erdafitinib and current treatment landscape for advanced bladder cancer ( Dr Yohann Loriot and Prof Arlene Siefker-Radtke )
5 Jun 2023
The current status of multiple myeloma diagnosis and treatment
Dr Patricio Duarte - Instituto Universitario CEMIC, Buenos Aires, Argentina
The current status of multiple myeloma diagnosis and treatment ( Dr Patricio Duarte - Instituto Universitario CEMIC, Buenos Aires, Argentina )
24 May 2023
Choosing Wisely in pathology
Dr Angela Mlole - Ocean Road Cancer Institute, Dar es Salaam, Tanzania
Choosing Wisely in pathology ( Dr Angela Mlole - Ocean Road Cancer Institute, Dar es Salaam, Tanzania )
18 May 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation